Sanofi, Enteris to Develop Oral Diabetes Therapy
By
Sanofi has initiated a feasibility study agreement with Enteris BioPharma, a Boonton, New Jersey-headquartered biotechnology company, which will leverage Enteris’ proprietary and patented oral peptide and small-molecule delivery platform, Peptelligence,…
Ropack Partners with TraceLink for Serialization
By
Ropack Pharma Solutions, a Montreal, Quebec, Canada-headquartered contract development and manufacturing organization, has selected TraceLink, a North Reading, Massachusetts-based track-and-trace solutions provider, to provide serialization solutions for Ropack’s customers using TraceLink’s…
Sharp, Ashfield to Launch Diurnal’s Pediatric Drug
By
Diurnal Group, a Cardiff, UK-headquartered specialty pharmaceutical company targeting chronic endocrine diseases, has signed agreements with Sharp Packaging Services and Ashfield Healthcare, divisions of UDG Healthcare, a Dublin, Ireland-headquartered contract…
Almac Launches Temperature-Management Software
By
Almac Group, a Craigavon, Ireland-based contract pharmaceutical development and manufacturing organization, has launched new temperature-management software, TempEZ, a GDP (good distribution practice)-compliant web-based platform that provides a single database to store…
Lilly Terminates $570-Million Insulin Partnership
By
Eli Lilly and Company has terminated its $570-million collaboration research and license agreement with Adocia, a Lyon, France-headquartered clinical-stage biopharmaceutical company that specializes in developing new formulations for already approved…